Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts

Molecular and Cellular Biology

Volumn 20, Issue 18, 2000, Pages 6741-6754

  Dulic, V ^a   Beney, G E ^a   Frebourg, G ^a   Drullinger, L F ^a   Stein, G H ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN E; PROTEIN P16; PROTEIN P21; PROTEIN P27;

AGING; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; LIFESPAN; MITOSIS; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SENESCENCE;

ANIMALS; CDC2-CDC28 KINASES; CELL AGING; CELL CYCLE; CELLS, CULTURED; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; FIBROBLASTS; G1 PHASE; GENE EXPRESSION; HUMANS; MICE; MITOSIS; ONCOGENE PROTEINS, VIRAL; PHENOTYPE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033816629     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.18.6741-6754.2000     Document Type: Article

References (72)

1. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts
2. Increased activity of p53 in senescing fibroblasts
3. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes
4. Control of replicative life span in human cells: Barriers to clonal expansion intermediate between M1 senescence and M2 crisis
5. Escape from senescence in human diploid fibroblasts induced directly by mutant p53
6. Cyclin E/Cdk2 activity is controlled by different mechanisms in the GO and G1 phases of the cell cycle
7. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts
8. Radiation-induced cell cycle arrest compromised by p21 deficiency
9. Requirement for p53 and p21 to sustain G2 arrest after DNA damage
10. Two posttranscriptional pathways that regulate p21(Cip1/Waf1/Sdi1) are identified by HPV16-E6 interaction and correlate with life span and cellular senescence
11. The biology of replicative senescence
12. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization
13. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
14. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
15. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor
16. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
17. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: Accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes
18. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
19. 2/M-phase transition
20. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb
21. Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein
22. The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein E6TP1, and target it for degradation
23. Role of the retinoblastoma protein family, pRb, p107, and p130 in the negative control of cell growth
24. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence
25. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
26. The limited in vitro lifetime of human diploid cell strains
27. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1)
28. Functions of the retinoblastoma protein
29. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
30. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2
31. Increased p53 protein associated with aging in human diploid fibroblasts
32. New functional activities for the p21 family of CDK inhibitors
33. p53: Only ARF the story
34. Cyclin E-induced S phase without activation of the pRb/E2F pathway
35. p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: Molecular mechanisms and implications for oncogenesis
36. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
37. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts
38. Expression of p21 is not required for senescence of human fibroblasts
39. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells
40. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts
41. Induction of p21(WAF1/C1P1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a)
42. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
43. 1-to-S phase transition
44. Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status
45. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras
46. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution
47. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction
48. 1-to-S transition
49. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts
50. Protein phosphatase type 1, the product of the retinoblastoma susceptibility gene, and cell cycle control
51. Role of the INK4a locus in tumor suppression and cell mortality
52. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
53. A role for both RB and p53 in the regulation of human cellular senescence
54. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen
55. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts
56. Microarray analysis of replicative senescence
57. CDK inhibitors: Positive and negative regulators of G1-phase progression
58. Deregulated cyclin E induces chromosome instability
59. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts
60. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts
61. Origins of G1 arrest in senescent human fibroblasts
62. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
63. Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types
64. The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase
65. Differentiation between senescence (M1) and crisis (M2) in human fibroblast cultures
66. Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases
67. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation
68. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins
69. p19(Skp1) and p45(Skp2) are essential elements of the cyclin A-CDK2 S phase kinase
70. Senescence of human fibroblasts induced by oncogenic Raf
71. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300
72. Expression of the pl6lNK4a tumor suppressor versus other INK4 family members during mouse development and aging